NSE filing, NSE: BIOPOL. Summary written from the filing by ALFA Finder's alert engine.
Biopol Chemicals Ltd: key numbers
- Share price
- ₹43.50
- Market cap
- ₹47.00 Cr
- Revenue (annual)
- ₹81.14 Cr
- Net profit (annual)
- ₹8.97 Cr
- P/E (TTM)
- 5.2×Sector 34.5×
- Promoter holding
- 65.81%+0.00% QoQ
- FII holding
- 0.47%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Biopol Chemicals Ltd
All →Biopol Chemicals Board Meeting Date
Biopol Chemicals Limited scheduled a board meeting for November 5, 2026, to consider and approve its unaudited standalone financial results for the half-year ending September 2026.
Biopol Chemicals Management Change
Biopol Chemicals Limited regularised the appointment of Mr. Sukhomoy Das as an Independent Director for a five-year term, effective June 11, 2026, following shareholder approval.
Biopol Chemicals Annual General Meeting
Biopol Chemicals Limited held its 3rd Annual General Meeting on September 22, 2026, via video conferencing. The meeting transacted ordinary and special business items.
Biopol Chemicals Business Update
Biopol Chemicals Limited participated in the 53rd Dye+Chem Bangladesh 2026 International Expo held in Dhaka from September 2 to September 5, 2026.
Biopol Chemicals Price Movement Clarification
Biopol Chemicals Limited clarified that recent share price movements are entirely market-driven. The company confirmed it has no undisclosed material information affecting trading volume or price.
Biopol Chemicals Annual General Meeting
Biopol Chemicals Limited issued notice for its 3rd Annual General Meeting on September 22, 2026 via video conferencing. The agenda includes financial adoption and director appointments.
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.